If You Invested $1000 In Glaukos Stock 10 Years Ago, You Would Have This Much Today
Glaukos (NYSE:GKOS) has outperformed the market over the past 10 years by 3.9% on an annualized basis producing an average annual return of 17.45%. Currently, Glaukos has a market capitalization of $1
The Trade Desk to Leave S&P 500 as Bloom Energy, Everpure, Illumina Join Index
Bloom Energy Surges on Inclusion to S&P 500; Illumina, Everpure Also Added
Non-farm payrolls data rattled the broader U.S. stock market, yet AI hardware stocks surged against the trend. The semiconductor index rose more than 3%, with SanDisk jumping 12%.
The prospect of Federal Reserve rate hikes has weighed on overall valuations and certain software growth stocks, while the industrial logic underpinning demand for AI computing power, storage, and data center interconnectivity remains intact despite interest rate expectations. SK Hynix, a memory chip manufacturer, closed up more than 8%, and Coherent, an optical communications company, rose 6.6%. Market participants noted that the strong performance of chip stocks on Friday had "nothing to do" with the non-farm payrolls data, but was instead driven primarily by the ongoing sector rotation between semiconductors and software.
USA Rare Earth Rated New Buy as Jefferies Initiates Several Critical Metals Names
9 Financials Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity
Small-cap Bears Were Back. Was IWM the Warning Sign?
Barclays Maintains Overweight on Protagonist Therapeutics, Raises Price Target to $180
Barclays analyst Etzer Darout maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Overweight and raises the price target from $153 to $180.
Apple To $303? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Cantor
BMO Capital Maintains Outperform on Protagonist Therapeutics, Raises Price Target to $190
BMO Capital analyst Etzer Darout maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Outperform and raises the price target from $178 to $190.
Takeda Secures FDA Approval For First-In-Class Blood Cancer Drug
On Friday, the U.S. Food and Drug Administration (FDA) approved Takeda Pharmaceutical Co. Ltd.'s (NYSE:TAK) MIMRYLO (rusfertide) for polycythemia vera, a type of blood cancer.How MIMRYLO Combats
The New Space ETFs Keep Buying the Same Names: Rocket Lab, AST SpaceMobile, SpaceX
The space ETF market is undergoing a shift of its own as investors move beyond traditional aerospace and defense companies toward businesses building the commercial infrastructure of the space
Victoria's Secret Leads Quant Rating Amid Mid-cap Consumer Discretionary Stocks
Take Salesforce as an example: AI is transforming software pricing models.
Salesforce allows customers to pay based on business outcomes—moving beyond mere task计量 to a model where it charges $2 only after helping the client earn $20. OpenAI, Sierra, and others are also adopting this "pay upon task completion" approach. However, outcome-based pricing carries inherent attribution risks: should performance be credited to AI or to marketing efforts? This pricing experiment will determine whether established software giants can successfully reinvent themselves amid the AI wave.
Trump signs executive order to establish the United States Space Force Academy
① Trump signed an executive order to establish the United States Space Academy, a dual-use institution serving both military and civilian purposes, with an educational model modeled after U.S. military academies such as West Point; ② The academy aims to cultivate professional talent in the aerospace sector. NASA leads an eight-member committee responsible for providing recommendations on its establishment, while the site location has yet to be determined.
Catalyst Watch: Jobs Report, Cybercab Event, and Apple Gets a New CEO
J&J Granted China Nod for Oral Psoriasis Pill Developed With Protagonist
Nasdaq 100 Falls As Warsh Revives Rate Hike Bets: Stock Market Today
The Nasdaq 100 slid 1% to 29,359 as Wall Street handed back a chunk of Thursday's Nvidia-powered tech rally on Friday after Federal Reserve Chair Kevin Warsh used his first Jackson Hole speech to
BMO ASSET MANAGEMENT INC S&P US SMALL CAP INDEX ETF: INTERIM MANAGEMENT REPORT OF FUND PERFORMANCE FR
BMO ASSET MANAGEMENT INC S&P US SMALL CAP INDEX ETF: INTERIM MANAGEMENT REPORT OF FUND PERFORMANCE EN